Association Between the Tissue and Circulating Advanced Glycation End-Products and the Micro- and Macrovascular Complications in Type 1 Diabetes: The DIABAGE Study.

Date publication

juillet 2022

Journal

Diabetes therapy : research, treatment and education of diabetes and related disorders

Auteurs

Membres identifiés du Cancéropôle Est :
Pr GILLERY Philippe

Tous les auteurs :
Diallo AM, Jaisson S, Barriquand R, Lukas C, Barraud S, Decoudier B, Francois M, Ly S, Mahmoudi R, Arndt C, Nazeyrollas P, Gillery P, Delemer B

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/35779209

Résumé

Type 1 diabetes is associated with an increased risk of vascular complications. We aimed to investigate the association between serum and tissue advanced glycation end-products (AGEs) and micro- and macrovascular complications in type 1 diabetes (T1D).

Mots clés

Advanced glycation end-products, Carboxymethyllysine, Macroangiopathy, Methylglyoxal, Microangiopathy, Pentosidine, Skin autofluorescence, Type 1 diabetes, Vascular complications

Référence

Diabetes Ther. 2022 07 2;: